Distinguishing features of microglia- and monocyte-derived macrophages after stroke

Golo Kronenberg1,2,3, Ria Uhlemann1, Nadine Richter4

  • 1Center for Stroke Research, Klinik für Neurologie, and Department of Experimental Neurology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.

Acta Neuropathologica
|December 18, 2017
PubMed

Insights

Resident microglia and infiltrating blood monocytes exhibit distinct gene expression profiles and activation states following ischemic stroke. Targeting these differences may improve stroke outcomes.

Area of Science:

  • Neuroscience
  • Immunology
  • Genomics

Background:

  • Following stroke, brain macrophages originate from resident microglia or infiltrating monocytes.
  • Understanding the distinct roles of these cell types is crucial for developing effective stroke therapies.

Purpose of the Study:

  • To differentiate the cellular responses of microglia and blood-derived macrophages in the ischemic brain.
  • To identify unique genomic signatures and functional characteristics of each cell type post-stroke.

Main Methods:

  • Utilized bone marrow chimerism and dual-reporter transgenic fate mapping in a mouse model of transient middle cerebral artery occlusion (MCAo).
  • Performed gene expression analysis at 7 days post-MCAo to identify cell-specific transcripts.
  • Conducted whole-cell patch-clamp analysis to assess cellular electrophysiological properties.

Main Results:

  • Identified 472 monocyte-specific and 970 microglia-specific transcripts in the ischemic brain.
  • Monocytes showed enrichment in migration, proliferation, and calcium signaling, indicating heightened activation.
  • Blood-derived macrophages exhibited a greater M2 neuroprotective phenotype bias compared to microglia.

Conclusions:

  • Established significant differences in activation states and genomic signatures between microglia and infiltrating macrophages post-stroke.
  • Demonstrated that impaired blood-borne cell engraftment exacerbates stroke lesion size and sensorimotor deficits.
  • Highlights the therapeutic potential of modulating these distinct immune cell populations after stroke.

Related Concept Videos